Cadila Healthcare, one of the leading pharmaceutical companies, announced that its wholly-owned subsidiary Zydus Healthcare has entered into an agreement on Sep. 20, 2021 with Integrace (Purchaser) to sell two brands viz. Mifegest and Cytolog.

The said transaction is expected to be completed within 30 days from the date of execution of agreement, subject to customary approvals. Purchaser is a part of the portfolio companies of PE firm True North.

Shares of the company gained Rs 3.80, or 0.70%, to settle  at  Rs 550.15.  The total volume of shares traded  was 212,650 at  the BSE (Tuesday). The scrip has touched an intraday high of 553 and low of 533.45.